Fresenius Medical Care AG

BRSE:FME Stock Report

Market Cap: CHF 12.0b

Fresenius Medical Care Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of FME?
Owner TypeNumber of SharesOwnership Percentage
Private Companies58,1730.0198%
Individual Insiders62,8560.0214%
General Public75,801,89025.8%
Public Companies94,380,38232.2%
Institutions123,110,14842%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 68.43% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
32.2%
Fresenius SE & Co. KGaA
94,380,382CHF 3.9b0%no data
7.49%
Dodge & Cox
21,985,617CHF 899.6m-0.11%0.34%
4.95%
Harris Associates L.P.
14,526,582CHF 594.4m-4.26%0.81%
4.34%
BlackRock, Inc.
12,738,437CHF 521.2m39.8%0.01%
4.25%
Pzena Investment Management, Inc.
12,480,509CHF 510.7m0.13%1.1%
2.81%
The Vanguard Group, Inc.
8,239,775CHF 337.2m0.04%0.01%
2.21%
Artisan Partners Limited Partnership
6,480,973CHF 265.2m0%0.23%
2%
Fiduciary Management, Inc.
5,867,592CHF 240.1m24.3%1.87%
1.16%
Fidelity International Ltd
3,405,809CHF 139.4m0%0.07%
0.96%
Lazard Asset Management LLC
2,817,730CHF 115.3m2.51%0.12%
0.81%
Dimensional Fund Advisors LP
2,362,437CHF 96.7m0.97%0.02%
0.66%
Deka Investment GmbH
1,944,436CHF 79.6m-14.9%0.08%
0.6%
Geode Capital Management, LLC
1,761,699CHF 72.1m0.07%0.01%
0.57%
Columbia Management Investment Advisers, LLC
1,678,583CHF 68.7m2.5%0.02%
0.44%
Norges Bank Investment Management
1,278,560CHF 52.3m0%no data
0.43%
Amundi Asset Management SAS
1,266,990CHF 51.8m6.78%0.01%
0.39%
SEI Investments Management Corporation
1,158,081CHF 47.4m-5.99%0.1%
0.39%
Charles Schwab Investment Management, Inc.
1,140,823CHF 46.7m1.27%0.01%
0.32%
Baillie Gifford & Co.
951,352CHF 38.9m-0.79%0.02%
0.29%
Invesco Ltd.
846,347CHF 34.6m0.31%0.01%
0.25%
M&G Investment Management Limited
726,383CHF 29.7m0%0.07%
0.24%
Deutsche Asset & Wealth Management
695,548CHF 28.5m-0.01%0.01%
0.23%
UBS Asset Management AG
687,903CHF 28.1m15.7%no data
0.23%
Eurizon Capital S.A.
680,519CHF 27.8m0%0.22%
0.23%
Allianz Asset Management GmbH
666,736CHF 27.3m0%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 22:13
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fresenius Medical Care AG is covered by 59 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martin SchneeAlphaValue
Brian WilliamsAvondale Partners
Olav ZilianBaader Helvea Equity Research